Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.29 - $0.57 $2,826 - $5,554
-9,745 Reduced 39.0%
15,240 $5,000
Q3 2022

Nov 14, 2022

BUY
$0.53 - $1.9 $7,645 - $27,407
14,425 Added 136.6%
24,985 $13,000
Q3 2022

Nov 14, 2022

BUY
$0.53 - $1.9 $7,645 - $27,407
14,425 Added 136.6%
24,985 $13,000
Q2 2022

Aug 16, 2022

BUY
$1.58 - $7.36 $16,684 - $77,721
10,560 New
10,560 $17,000

About Tonix Pharmaceuticals Holding Corp.


  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.25M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.